NCT06926218

This Study is to Evaluate the Safety, Tolerability, and Pharmacokinetics (PK) of HSK47388 in Healthy Volunteers

A Randomized, Double-blind, Placebo-controlled, Single Ascending Dose Study to Evaluate the Safety, Tolerability and Pharmacokinetics of HSK47388 in Healthy Volunteers

• Status: Not Yet Recruiting
• Phase: Phase 1
• Study type: Interventional
• Enrollment: 40 (estimated)
• Sponsor: Haisco Pharmaceutical Group Co., Ltd. · Industry
• Sex: All
• Age: 18 Years – 55 Years
• Healthy volunteers: Accepted

Summary

This is a single-center, randomized, double-blind, placebo-controlled, SAD study to evaluate the safety, tolerability and PK of HSK47388 in healthy adult participants and preliminarily evaluate the PD of HSK47388

Conditions

• Healthy

Interventions

Type	Name	Description
DRUG	HSK47388	cohort 1 to cohort 5
DRUG	Placebo	cohort 1 to cohort 5

Timeline

• Start date: 2025-05-01
• Primary completion: 2025-07-01
• Completion: 2025-09-01
• First posted: 2025-04-13
• Last updated: 2025-04-13

Locations

1 site across 1 country: Australia